CD4 and myeloid sarcoma: Given the previous implications of activated CD4+ T cells in the pathophysiology of MS, we had generated, in parallel, a dataset of ex vivo activated CD4+ T cells using a subset of the PhenoGenetic subjects (n = 28) to investigate the effect of ex vivo activation on the methylation of CpGs of interest.